221456-43-5Relevant articles and documents
Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs
Fujita, Masakazu,Seki, Taketsugu,Inada, Haruaki,Shimizu, Kazuhiro,Takahama, Akane,Sano, Tetsuro
, p. 341 - 344 (2007/10/03)
A series of compounds (22-36) which possess dual-acting PAF antagonist/TxSI have been generated by the approach of linking the known PAF antagonists and TxIs, such as Ridogrel (1).